Quantum BioPharma Ltd.
QNTM
$3.89
-$0.16-3.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.26% | -84.30% | -178.49% | -261.70% | -111.98% |
| Total Depreciation and Amortization | 8.68% | 11.27% | 5.86% | -4.03% | -66.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,978.57% | 576.45% | 3,565.04% | 499.68% | 179.21% |
| Change in Net Operating Assets | -115.09% | -79.65% | 180.31% | 97.94% | 880.12% |
| Cash from Operations | 38.40% | -19.78% | -27.20% | -104.24% | -13.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.45% | -29.86% | 61.45% | -1,289.08% | -775.30% |
| Cash from Investing | -23.45% | -29.86% | 61.45% | -1,204.39% | -870.72% |
| Total Debt Issued | 29.80% | 429.40% | -- | 1,809.78% | 1,236.98% |
| Total Debt Repaid | -3,509.82% | -2,429.83% | -1,390.54% | -701.46% | 51.64% |
| Issuance of Common Stock | -43.58% | -95.04% | -81.74% | 307.64% | 3,283.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -29.75% | -47.51% | -21.63% | 484.07% | 3,083.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.35% | -226.30% | -420.60% | 23.48% | 127.72% |